CYP2E1 and lung carcinoma: To determine if CYP2E1 is a therapeutic target for lung cancer, we established the Lewis lung orthotopic xenograft model using Cyp2e1 knockout (Cyp2e1−/−) mice, and H&E staining was performed to identify the tumor (Figure 1B–D).